Top Markets
#1 ADO Protocol ADO Protocol +193.85%
#2 GoPlus Security GoPlus Security +36.55%
#3 GAIB AID GAIB AID +24.67%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.22%
#5 Tutorial Tutorial +16.90%
#6 SkyAI SkyAI +16.67%
#7 Pons Pons +13.86%
#8 Verus Coin Verus Coin +13.11%
#9 Status Status +12.83%
#10 o1.exchange o1.exchange +12.80%
Coin of the day
ADO Protocol ADO Protocol
設定
言語
日本
通貨
USD
テーマ
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
株式のランク #33996
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
株価
$0.1502
最終同期: 2024-11-04
時価総額
$6.43M
変化（1日）
-5.45%
変化（1年）
0.00%
国
US
取引 Renalytix Plc (RNLX)

カテゴリー

Healthcare
Renalytix Plc（RNLX）の発行済株式数
September 2024 時点の発行済株式数 52.85M
Renalytix Plc の最新の財務報告および株価によると、現在の発行済株式数は 52.85M です。June 2023 の終わりには、同社は 41.11M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Renalytix Plc（RNLX）の発行済株式数の履歴（2018 ～ 2026）
各年末時点の発行済株式数
年 発行済株式数 変化
2026 (TTM) 52.85M -2.29%
2024 54.09M 31.59%
2023 41.11M 20.93%
2022 33.99M -4.07%
2021 35.43M 22.38%
2020 28.95M 36.05%
2019 21.28M 1.82%
2018 20.90M 0.00%
類似企業や競合他社の発行済株式数
企業 発行済株式数 差 国
GE HealthCare Technologies Inc. GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc.
GEHC.US
 453.00M 757.16%
US
Pro Medicus Limited Pro Medicus Limited
Pro Medicus Limited
PME.AX
 104.48M 97.70%
AU
BrightSpring Health Services, Inc. Common Stock BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. Common Stock
BTSG.US
 205.38M 288.62%
US
Tempus AI, Inc. Tempus AI, Inc.
Tempus AI, Inc.
TEM.US
 179.92M 240.44%
US
Signify Health, Inc. Signify Health, Inc.
Signify Health, Inc.
SGFY.US
 - -
US